India Urged to Ban Smoking Zones in Hotels, Restaurants, Airports

Regulations by 2FIRSTS.ai
Mar.14.2024
India Urged to Ban Smoking Zones in Hotels, Restaurants, Airports
Doctors, cancer patients, and hotels are urging the Indian government to ban designated smoking areas in public places.

According to a report by telegraphindia, doctors, cancer patients, and hotels are urging the Indian government to ban designated smoking rooms in hotels, restaurants, and airports in order to protect the public from secondhand smoke.

 

Dr. Harit Chaturvedi, Chair of Cancer Care at Kesar Medical Center, stated: "Smoking exacerbates lung function impairment and lowers immunity. All designated smoking areas in hotels, restaurants, and even airports should be abolished to ensure a completely smoke-free environment. Most designated smoking areas rarely meet the requirements of COTPA, exposing our public to significant health risks due to secondhand smoke inhalation."

 

According to the 2003 Cigarettes and Other Tobacco Products Act (COTPA), smoking is prohibited in all public places. However, smoking is still allowed in designated smoking areas in some public places such as restaurants, hotels, and airports.

 

Health activity expert Nalini Satyanarayan stated, "Passive smoking mostly occurs in restaurants, especially in hotels, eateries, bars, clubs, etc. Cigarette smoke can permeate from smoking zones into public areas. The COTPA needs to be amended to prohibit smoking in any location, as this aligns with the best interests of public health."

 

Currently, the Indian government has initiated the process of amending COTPA and has introduced the 2020 Amendment to the Tobacco Products (Prohibition of Advertisement and Regulation of Trade, Commerce, Production, Supply and Distribution) Act.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International’s U.S. affiliate (PMI America) has released a new white paper stating that U.S. healthcare professionals hold serious misconceptions about smoke-free products, with nearly half incorrectly believing that nicotine causes cancer. As a result, smokers are being denied scientifically accurate harm-reduction advice. The report calls on the U.S. Food and Drug Administration (FDA) to deliver accurate information on smoke-free alternatives to physicians, so they can help adul
Aug.19 by 2FIRSTS.ai
Altria Partners with U.S. Golf Course Association to Offer Members Discounted on! Nicotine Pouches
Altria Partners with U.S. Golf Course Association to Offer Members Discounted on! Nicotine Pouches
The National Golf Course Owners Association (NGCOA) has partnered with Altria to offer its members discounted on!® nicotine pouches through the NGCOA platform. In 2024, shipments from Altria’s Helix unit surged 40%, with on!® sales topping 160 million cans.
Jul.15 by 2FIRSTS.ai
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts spoke with the leadership team at ARAC to analyze the regulatory context and industry implications of the FDA’s approval of five Juul products. ARAC noted that the decision highlights FDA’s increasing emphasis on real-world switching behavior as a key criterion for authorization. While more MGOs may follow, companies must meet rigorous standards in toxicology, manufacturing, and population-level risk assessments.
Jul.21
MK Lab CEO Offers In-Depth Analysis of Japan's E-Cigarette Market at 2Firsts Forum: Regulations, User Trends, and Marketing Strategies
MK Lab CEO Offers In-Depth Analysis of Japan's E-Cigarette Market at 2Firsts Forum: Regulations, User Trends, and Marketing Strategies
At the 2Firsts Global NGP Forum, MK Lab CEO KUNIYOSHI/MAKIO provided an in-depth analysis of Japan's e-cigarette market, examining regulatory constraints, consumer trends, and localized marketing strategies. He emphasized that viewing "product as culture" is key to overcoming regulatory and user barriers.
Jul.30 by 2FIRSTS.ai
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
A new Australian study found flavored nicotine e-cigarettes are three times more effective than gum or lozenges for quitting smoking. The trial of 1,000 smokers on government support showed higher quit rates with vaping, but long-term health risks remain unclear.
Jul.17 by 2FIRSTS.ai
Singapore's Woodlands Checkpoint Seizes Over 5,900 Vaping Products; Case Referred for Investigation
Singapore's Woodlands Checkpoint Seizes Over 5,900 Vaping Products; Case Referred for Investigation
On July 24, Singapore’s Immigration & Checkpoints Authority (ICA) conducted an enhanced inspection of a Malaysia-registered vehicle at Woodlands Checkpoint and uncovered more than 5,900 e-cigarettes and related components, along with 150 heat-not-burn tobacco sticks concealed in multiple compartments. The case has been handed over to the Health Sciences Authority for further investigation, thwarting the smuggling attempt.
Aug.06 by 2FIRSTS.ai